CHEMOMAB THERAPEUTICS LTD

CUSIP: 16385C104 Class: SPONSORED ADS

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 940,990 Value ($000) $1,092 Avg Close — Range —
Q1 2025
Shares 1,741,273 Value ($000) $1,898 Avg Close — Range —
Q4 2024
Shares 1,741,273 Value ($000) $3,152 Avg Close — Range —
Q3 2024
Shares 1,741,273 Value ($000) $2,734 Avg Close — Range —
Q2 2024
Shares 2,241,273 Value ($000) $2,045 Avg Close — Range —
Q1 2024
Shares 2,241,274 Value ($000) $1,746 Avg Close — Range —
Q4 2023
Shares 2,241,274 Value ($000) $1,143 Avg Close — Range —
Q3 2023
Shares 2,241,274 Value ($000) $2,006 Avg Close — Range —
Q2 2023
Shares 2,241,274 Value ($000) $2,947 Avg Close — Range —
Q1 2023
Shares 2,241,274 Value ($000) $3,564 Avg Close — Range —
Q4 2022
Shares 2,578,174 Value ($000) $8,250 Avg Close — Range —
Q3 2022
Shares 2,578,174 Value ($000) $6,420 Avg Close — Range —
Q2 2022
Shares 2,578,174 Value ($000) $9,539 Avg Close — Range —
Q1 2022
Shares 2,578,174 Value ($000) $12,375 Avg Close — Range —
Q4 2021
Shares 2,578,174 Value ($000) $17,789 Avg Close — Range —
Q3 2021
Shares 2,578,174 Value ($000) $28,566 Avg Close — Range —
Q2 2021
Shares 2,578,174 Value ($000) $49,037 Avg Close — Range —
Q1 2021
Shares 2,578,174 Value ($000) $74,019 Avg Close — Range —